Vol VI, Issue 4 Date of Publication: October 11, 2021
DOI: https://doi.org/10.20529/IJME.2021.044

Views
, PDF Downloads:

Commercialisation of healthcare in India: Covid-19 and beyond

Bijoya Roy
Abstract:
This review of the government’s policy during the pandemic flags a number of ethical concerns. The private healthcare sector’s treatment of Covid-19 patients has generated mistrust and anger. However, the government has not held it accountable and instead commercialisation has subverted the pandemic needs. Government hospitals weakened by decades of cuts are exposed to internal reorganisation of services through the public-private partnership mechanism, a neoliberal policy that has persisted through the pandemic. There is a need to re-examine the government’s policy reliance on scaling-up coverage through the private sector in the pandemic and after.


Copyright and license
©Indian Journal of Medical Ethics 2021: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0),
which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.

Full Text

HTML | PDF

Leave a Reply

Your email address will not be published. Required fields are marked *
Please restrict your comment preferably to 800 words
Comments are moderated. Approval can take up to 48 hours.

Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation